Originally published In Press as doi:10.1074/jbc.M700733200 on September 5, 2007
J. Biol. Chem., Vol. 282, Issue 44, 31928-31936, November 2, 2007
Cadmium Trapping in an Epithelial Sodium Channel Pore Mutant*
Armelle-Natsuo Takeda1,
Ivan Gautschi,
Miguel X. van Bemmelen, and
Laurent Schild2
From the
Department of Pharmacology and Toxicology, Faculty of Biology and Medicine, Lausanne University, CH-1005 Lausanne, Switzerland
Received for publication, January 25, 2007
, and in revised form, September 3, 2007.
 |
ABSTRACT
|
|---|
The putative selectivity filter of the epithelial sodium channel (ENaC) comprises a three-residue sequence G/SXS, but it remains uncertain whether the backbone atoms of this sequence or whether their side chains are lining the pore. It has been reported that the S589C mutation in the selectivity filter of
ENaC renders the channel sensitive to block by externally applied Cd2+; this was interpreted as evidence for Cd2+ coordination with the thiol group of the side chain of
589C, pointing toward the pore lumen. Because the
S589C mutation alters the monovalent to divalent cation selectivity ratio of ENaC and because internally applied Cd2+ blocks wild-type ENaC with high affinity, we hypothesized that the inhibition of
S589C ENaC by Cd2+ results rather from the coordination of this cation with native cysteine residues located in the internal pore of ENaC. We show here that Cd2+ inhibits not only ENaC
S589C and
S589D but also
S589N mutants and that Ca2+ weakly interacts with the S589D mutant. The block of
S589C, -D, and -N mutants is characterized by a slow on-rate, is nearly irreversible, is voltage-dependent, and can be prevented by amiloride. The C546S mutation in the second transmembrane helix of
subunit in the background of the ENaC
S589C, -D, or -N mutants reduces the sensitivity to block by Cd2+ and renders the block rapidly reversible. We conclude therefore that the block by Cd2+ of the
S589C, -D, and -N mutants results from the trapping of Cd2+ ions in the internal pore of the channel and involves Cys-546 in the second transmembrane helix of the
ENaC subunit.
 |
INTRODUCTION
|
|---|
The epithelial sodium channel (ENaC)3 mediates the Na+ ion influx across the apical membrane of tight epithelia such as the aldosterone-sensitive distal nephron, the distal colon, or the airways epithelium (1). In principal cells of the aldosterone-sensitive distal nephron, the ENaC-mediated influx of Na+ ions constitutes the apical step of the transepithelial Na+ absorption and is regulated by aldosterone (2). The aldosterone-sensitive distal nephron plays an important role in the maintenance of Na+ homeostasis, the regulation of extracellular volume, and blood pressure (3). In the lungs, ENaC together with cystic fibrosis transmembrane conductance regulator controls the height of the airway surface liquid that forms a thin layer coating the airways epithelium, which contributes to the clearance of particles and microbes (4).
Functional ENaC at the cell plasma membrane is a heteromeric protein made of homologous
,
, and
subunits arranged pseudosymetrically around a central channel pore, presumably in a 2
, 1
, and 1
configuration (5, 6). Each ENaC subunit is made of two transmembrane helices (TM1 and TM2), a large extracellular loop that represents more than half of the mass of the protein, and intracellular N and C termini. The ENaC subunits belong to the ENaC/degenerin superfamily of ion channels but share no sequence homology with other tetrameric channels also made of two transmembrane domains, such as inward rectifier K+ channels.
In the absence of crystal structures of members of the ENaC/degenerin ion channel family, our understanding of mechanisms and structures involved in the ion permeation is quite limited. The amino acid sequence preceding the second transmembrane domain (TM2) constitutes the outer channel pore (pore region in Fig. 1) where the pore blocker amiloride binds (
Ser-583,
Gly-525,
Gly-537 in rat ENaC sequence, see Fig. 1) (7). Secondary structure predictions conform the TM2 to an
helix (8). The amiloride binding site is located external and upstream to the selectivity filter with an amino-to-carboxyl sense. The conserved three-amino acid sequence G/SXS (587–589 in rat ENaC) that is essential to maintain the high selectivity of ENaC for Na+ over K+ or Ca2+ ions is considered therefore a key element of the selectivity filter (9). It has been proposed that the increase in permeability to K+ and NH +4 resulting from mutations of
Ser-589 reflects changes in the geometry of the pore segment comprising the selectivity filter that allow it to accommodate larger cations (10). The molecular basis of the interaction between the permeant Na2+ or Li2+ ions and oxygen atoms at the binding site is not yet clear. Recent experiments reported that the serine 589 to cysteine substitution in the
subunit (
S589C) confers to ENaC a sensitivity to block by external Cd2+ ions, which was interpreted as evidence for an orientation of the side chain of serine 589 toward the lumen of the channel pore (11).
ENaC and the K+ channel KcsA share a similar membrane topology and a heterotetrameric structure made of homologous subunits comprising two transmembrane segments. The conduction pore of ENaC appears to be, however, quite different from that of the members of the K+ channel superfamily. The amino-terminal portion of the pore region in the KcsA forms an
helix (pore helix) pointing from the outside toward the center of the channel (12). Following this pore helix, the amino acid stretch lining the selectivity filter folds back toward the external surface, exposing binding sites for external blocking ligands such as toxins or triethanolamine (TEA). In ENaC, the pore region points from the outside to the center of the channel with an amino-to-carboxyl sense of, successively, the amiloride binding site, the selectivity filter, and the TM2 (1).
These important differences in the pore organization indicate that the three-dimensional structure of the KcsA K+ channel does not represent an adequate template to understand ion permeation through ENaC. The pore-lining residues beyond the selectivity filter that constitute the internal channel pore remain to be identified in channels belonging to the ENaC/degenerin family, for which only a few studies have been performed to determine the accessibility of inner pore lining residues. Recent work has shown that, in contrast to the acid-sensing ion channel (ASIC), another member of the ENaC/degenerin family, ENaC is highly sensitive to intracellularly applied sulfhydryl reagents such as Cd2+, Zn2+, or methanethiosulfonates (MTS). Cysteine residues in the N terminus of ENaC contribute to inhibition by MTS reagents (13). Similar inhibition of ASIC by internal sulfhydryl reagents can be reproduced in ASIC mutants in which cysteines have been introduced at the N terminus and in the 5'-start of the TM1 (14). Altogether, these observations suggest that the N terminus and the internal part of TM1 participate in the pore lining of ENaC.
In this study we have revisited the mechanism of channel blockade by external Cd2+ in ENaC mutants with amino acid substitutions in the selectivity filter (
S589C) (11). We show that, in order to block ENaC, Cd2+ has to bind to distinct sites deep in the channel pore, including a cysteine residue in the TM2 of
ENaC subunits.
 |
MATERIALS AND METHODS
|
|---|
Site-directed Mutagenesis, Expression in Xenopus laevis Oocytes, and Electrophysiology—The ENaC constructs used for this study were taken from a previous study (10, 13). Complementary RNAs of each
,
,
subunit were synthesized in vitro with SP6 RNA polymerase from wild-type and mutant
,
, and
ENaC cDNA encoding vectors previously linearized with PvuII (
and
subunits) or BglII (
subunit).
Healthy stage V and VI X. laevis oocytes were pressure-injected with 100 nl of a solution containing equal amounts of
,
, and
ENaC subunits at a total concentration of 100 ng/µl. For standard experiments, oocytes were kept at 19 °C in a low Na+-modified Barth's saline: in mM, 10 NaCl, 0.82 MgSO4, 0.41 CaCl2, 0.33 Ca(NO3)2, 80 NMDG, 2 KCl, and 5 HEPES, pH 7.2.
Electrophysiological measurements were made 16–30 h after injection. ENaC current (INa) was recorded using the two-electrode voltage-clamp technique (model TEV-200; Dagan Corp.). Holding potential was–100 mV. The amiloride-sensitive currents defined as the difference in I measured before and after addition of 10 µM amiloride (Sigma-Aldrich) in the bath were considered ENaC-mediated macroscopic INa. All electrophysiological experiments were performed at room temperature (22–25 °C). Oocytes were maintained in a recording chamber continuously perfused with a standard bath solution containing in mM, 120 NaCl, 2.5 KCl, 1.8 CaCl2-2H2O, and 10 HEPES-NaOH, pH 7.2. For cadmium block experiments, 0.01, 0.1, 1, or 10 mM Cd2+ was freshly added to the perfusion solution. Results are reported as means ± S.E. and represent the mean of n independent experiments in which the average amiloride-sensitive Na+ current INa was measured for four to ten individual oocytes originating from different frogs.
Analysis of the Data—Data obtained from the time course of INa decrease in the presence of external Cd2+ were best fitted by the sum of two exponentials. To analyze the voltage dependence curve of the INa current of the ENaC mutant, the ratio I/I0 measured in presence (I) of 1 or 3 mM Cd2+ to that in the absence of the Cd2+ (I0) is described by the Woodhull equation (15) as shown in Equation 1
 | (Eq. 1) |
where Pun is the probability that the binding site of Cd2+ is unblocked; KB(0) is the equilibrium dissociation constant at 0 mV; [B] is the blocker concentration; z' is the slope parameter; F, the Faraday's constant; V, the applied voltage; R, the gas constant, and T, the absolute temperature. Moreover, z' is equal to the product of the actual valence of the blocking ion z and the fraction of the membrane potential (or electrical distance)
acting on the ion: z'= z
.
 |
RESULTS
|
|---|
It has recently been reported that serine-to-cysteine substitution at position 589 in
ENaC makes the channel inhibitable by external Cd2+ (11). The block of ENaC
S589C mutant by Cd2+ shows an unusual slow on-rate (kon > 1000 M–1s–1), as well as a slow and incomplete recovery of ENaC activity after external Cd2+ removal. This was interpreted as evidence for Cd2+ coordination with the thiol group of the side chain of the cysteine at position
589 (11).
Ser-589 is located in the selectivity filter sequence G587S588S589 of rat ENaC (see Fig. 2), and its mutation drastically changes the ion selectivity of the channel (9, 10). We hypothesized that these unusual characteristics of block by Cd2+ are due to the trapping of Cd2+ ions in the internal pore of the channel, i.e. downstream the selectivity filter as far as the channel opening to the cytosol. Two previous observations support this hypothesis. First, the
S589C mutation makes the channel permeable to divalent cations such as Ca2+ and possibly also to Cd2+, which has a smaller ionic radius than the former (9). Second, we have recently reported that, in both inside-out patch and in cut-open oocytes, Cd2+ applied at micromolar concentrations to the intracellular side of ENaC blocks the channel; this block was characterized by a slow and partial recovery upon removal of Cd2+ (13).

View larger version (22K):
[in this window]
[in a new window]
|
FIGURE 2. Current inhibition of the Ser-589, , mutants by external Cd2+. Representative tracings of macroscopic ENaC (INa) currents obtained in oocytes injected with ENaC S589C, , (A); S589D, , (B); S589N, , (C); S589A, , (D); or , , wild-type (E). Removal of amiloride (10 µM) in the bath induced a robust inward Na+ current. The addition of 0.1 or 1 mM external Cd2+ (A–C) decreased INa, whereas 10 mM Cd2+ decreased INa of the S589A, , (D). The wild-type ENaC (E) remained insensitive to 10 mM cadmium.
|
|
To determine the requirement of a thiol side chain at position
589 for the binding of external Cd2+ and the inhibition of ENaC, we tested its effect on different substitution mutants, e.g.
S589C,
S589D,
S589N, and
S589A. Cd2+ ions are known to bind the sulfhydryl group of cysteine or the fully charged oxygen atoms contributed by glutamate or aspartate side chains; however, Cd2+ has little affinity for side chains of asparagine. Fig. 2 shows representative recordings of ENaC-mediated amiloride-sensitive currents (INa) and their inhibition by external Cd2+. Cadmium at 0.1 or 1 mM inhibits the INa generated by ENaC
S589C,
S589D, and
S589N mutants (Fig. 2, A–C). A higher concentration of Cd2+ (10 mM) is required to inhibit the
S589A mutant (Fig. 2D), whereas wild-type ENaC remains insensitive to inhibition by Cd2+ (Fig. 2E).
The blockade of ENaC
Ser-589 mutants by Cd2+ slowly reaches equilibrium. This is particularly evident for low concentrations of Cd2+ and for the
S589N mutant, which appears slightly less sensitive to Cd2+ than the
S589C and
S589D counterparts. It was difficult to determine the true affinity of the
Ser-589 mutants for Cd2+ because at low Cd2+ concentrations the blockade equilibrium was still not reached after several minutes. At a higher concentration of Cd2+ (1 mM) the rate of channel inhibition is faster and the block almost complete after 1 min. This contrasts with the fast kinetics of inhibition of the
S583C ENaC mutant by Cd2+ at concentrations varying from 0.01 to 1 mM (IC50 = 0.105 ± 0.0012 mM, n = 10): external Cd2+ rapidly reduces the current level in a dose-dependent manner without changes in the on-rate of channel blockade (Fig. 3). By contrast to the
S589N, the
S583N mutant is insensitive to inhibition by external Cd2+. There is strong evidence that the side chain of the cysteine at position Ser-583 is oriented toward the channel lumen, allowing Cd2+ to bind in the external pore and to block the channel (16, 17). It also shows that Asn does not bind Cd2+ at any of the assayed concentrations, and we conclude therefore that the lower sensitivity of the
S589N mutant to Cd2+ inhibition probably results from a decreased permeability to this cation as compared with that of the other
589 mutants. Moreover, the discrepancy between the
Ser-589 and
Ser-583 mutants regarding their sensitivity to Cd2+ and the kinetics of block indicate that the mechanism of ENaC inhibition by Cd2+ is different for the two mutants.

View larger version (26K):
[in this window]
[in a new window]
|
FIGURE 3. Inhibition of S583C, , mutant by external Cd2+. A, representative tracings of macroscopic ENaC (INa) currents recorded in oocytes injected with EnaC , , , S583C, , , or S583N, , at increasing concentrations of Cd2+. B, dose-dependent inhibition of INa of the S583C, , ( ) by Cd2+ compared with the wild type ( ) and the S583N, , ( ). Fit of the data ( ) was obtained by simple Langmuir isotherm and gave a KD for Cd2+ of 0.105 ± 0.0012 mM.
|
|
The on-rate of channel inhibition by Cd2+ of the
S589C, -D, -N, and -A mutants is summarized in Fig. 4; the best fit of the data were obtained using the sum of two exponentials, consistent with two components of the ENaC block with a fast and a slow rate constant (Table 1). The data also show that increasing Cd2+ concentrations between 0.01 and 1 mM affect predominantly the time required to reach the equilibrium rather than the magnitude of current inhibition. From the extrapolation of the best fit of
Ser-589 channel inhibition, we can predict that, at equilibrium, the half-maximal inhibition (IC50) for Cd2+ is largely below 0.1 mM for the
S589C, -D, and -N mutants, suggesting a high affinity site for the Cd2+ binding site. However, the slow on-rate of the Cd2+ block points to the presence of important diffusional constraints in the
Ser-589 mutants for Cd2+ ions to bind at its blocking site. Interestingly, the conserved
S589A substitution, which only slightly modifies the cation selectivity of the channel compared with the
S589C, -D, and -N mutants, shows the slowest on-rate of Cd2+ block.
View this table:
[in this window]
[in a new window]
|
TABLE 1 Rate constants of the inhibition of ENaC mutants by external Cd2+
Rate constants were obtained from data on Figs. 4 and 5. Best fit of the data was obtained with the sum of two exponentials, except for inhibition of S589D and S589C by low (0.01 mM) concentration of Cd2+.
|
|

View larger version (39K):
[in this window]
[in a new window]
|
FIGURE 4. Time course of inhibition of ENaC current (INa) by Cd2+ in oocytes expressing the mutants S589C, , (n = 12) (A), S589D, , (n = 6) (B), S589N, , (n = 11) (C), or S589A, , (n = 6) (D) or expressing ENaC wild-type (open symbols). Inhibition curves were obtained with Cd2+ 0.01 mM ( ), 0.1 mM (), 1 mM ( ), and 10 mM ( ) for ENaC mutants and concentration up to 1 mM of Cd2+ for the wild type. Data were best fitted by the sum of two exponentials, and results are listed in Table 1.
|
|
We have also tested the ability of Zn2+ to block
S589C, -D, and -N ENaC mutants (Fig. 5). We observed that Zn2+, at similar concentrations, shows inhibition curves of INa that are superimposable to those obtained for Cd2+, indicating similar blocking kinetics for Cd2+ and Zn2+. We do not have any sound explanation for the stimulatory effect of external Zn2+ (1 mM) on ENaC wild type.
Another particularity of the blockade of the
S589C mutant by Cd2+ is the slow and partial recovery from inhibition. We asked whether differences may exist in the dissociation of Cd2+ from its blocking site (off-rate) among the
S589C,
S589D, and
S589N mutants. The tracings in Fig. 6A compare the
S589C, -D, and -N mutants with respect to the recovery from amiloride and Cd2+ block. The recovery from the channel inhibition by amiloride is rapid and nearly complete, whereas the recovery from Cd2+ blockade is considerably slower and incomplete. The amount of INa recovered 2 min after removal of external Cd2+ was similar for the three
Ser-589 mutants (Fig. 6C), indicating that coordination of Cd2+ at position
589 is not responsible for its slow dissociation rate. In comparison, the recovery from blockade by Cd2+ of the
S583C mutant is rapid and fully reversible (Fig. 6, B and C). These experiments further support our hypothesis that the mechanism of block of the
Ser-589 mutants by Cd2+ differs from the block of the S583C that involves direct coordination with the sulfhydryl side chain of the cysteine. Residues other than Cys or Asp introduced at position
Ser-589 likely participate in the channel inhibition by external Cd2+. It can be argued that mutations at
Ser-589 create a novel binding site that allows inhibition of INa by Cd2+ independently of the diffusion of this cation into the pore. However, if Cd2+ has to bind within the pore in order to block the channel, this inhibition should be prevented by the pore blocker amiloride. To test this hypothesis we took advantage of the slow and partial reversibility of ENaC block by Cd2+ and measured the recovery of INa from channel inhibition by Cd2+ when amiloride was simultaneously added to the external medium. Fig. 7A shows that the INa of the
S589C, -D, and -N mutants exposed to 1 mM Cd2+ in the presence of amiloride (10 µM) in the bath solution recovered rapidly and almost completely after removal of both blockers. These experiments demonstrate that amiloride prevents the irreversible inhibition of
Ser-589 mutants by Cd2+. These results are summarized in Fig. 7B in which it can be seen that the INa recovered after ENaC inhibition by amiloride and Cd2+ was identical to INa after the same control period. The interpretation of these results is that upon binding to its receptor at the external entrance of the channel pore (see Fig. 1), amiloride prevents the access of Cd2+ to its binding site located beyond that of amiloride. We conclude that in the
S589N, as in the
S589C or -D mutants, Cd2+ likely binds to cysteine residues within the channel pore at a site downstream or deeper relative to the amiloride binding site.

View larger version (40K):
[in this window]
[in a new window]
|
FIGURE 6. Slow and partial recovery of ENaC currents from Cd2+ block. A, Oocytes were injected with S589C, , , S589D, , , or S589N, , . Removal of amiloride induced a large and reversible INa. The addition of 1 mM Cd2+ inhibitedINa that slowly and partially recovered after Cd2+ removal.B, oocytes expressing S583C, , show a rapid and complete recovery of INa after inhibition by 1 mM Cd2+. Scale, x-axis, 1 min; y-axis, Cys, 3 µA, Asp, 5 µA, Asn 7 µA(A), 13 µA(B). C, normalized INa before, during, and 2 min after application of Cd2+ (1 mM) in the bath (n = 20).
|
|
For positively charged pore blockers binding within the transmembrane pore region, the large electric field across the membrane provides the energy to move the blocker along the channel pore. If Cd2+ binds within the transmembrane electric field, we expect the inhibition of
Ser-589 ENaC mutants by Cd2+ to be dependent on voltage across the membrane. Fig. 8 shows the INa inhibition of the
S589N and
S589C mutants by 1 and 3 mM extracellular Cd2+ at transmembrane voltages ranging from–120 to 0 mV. Inhibition of both mutants by Cd2+, arbitrarily determined 40 s after application, was clearly dependent on voltage, with a stronger inhibition at negative holding potentials. According to Woodhull's formulation, the slope parameter z' is equal to the product of the actual valence of the blocking ion (2 for Cd2+) and the fraction of the electrical distance,
, acting on Cd2+ at the binding site. The
values of 0.34 ± 0.05 and 0.42 ± 0.05 calculated for the voltage dependence of Cd2+ block of
S589N and
S589C, respectively, represent apparent relative distances in the electric field, because they were not determined at equilibrium. Still our data clearly indicate that Cd2+ binds to a site within the transmembrane electric field that is indistinguishable for both mutants.

View larger version (25K):
[in this window]
[in a new window]
|
FIGURE 7. The nearly irreversible INa inhibition by Cd2+ Nais prevented by amiloride. A, oocytes expressing S589C, , , S589D, , , or S589N, , , were exposed to external Cd2+ (1 mM) in the presence of 10 µM amiloride; INa completely recovered after removal of Cd2+ and amiloride. Scale, x-axis, 1 min; y-axis, Cys, 3µA, Asp, 5µA, Asn, 3µA. B, recovery of Cd2+ inhibition in the presence of amiloride (n = 6).
|
|
So far, our analysis of the current inhibition of ENaC
Ser-589 mutants by Cd2+ reveals that this cation binds to a site in the channel pore located deeper than the amiloride binding site and that the contribution of the substituted residue at position
589 in coordinating Cd2+ ions to block the channel is not essential since the
S589N substitution also confers to the channel a sensitivity to Cd2+. We further investigated this point by probing the
S589D mutant with external Ca2+ and looked for binding interactions between Ca2+ and the engineered aspartate side. The Ca2+ ions have an ionic radius comparable with Cd2+ or Zn2+. As shown in Fig. 9, Ca2+ at 10 mM in the external medium exerts only a modest inhibition of the
S589D mutant (
25% inhibition of INa) compared with Cd2+ or Zn2+ (Figs. 4 and 5). Furthermore, in contrast to Cd2+, the weak block by Ca2+ was rapidly and completely reversible.
Taken together, our experimental evidence does not support the participation of the side chain of the amino acids at position
Ser-589 in coordinating Cd2+, Zn2+, or Ca2+ ions, although such interaction cannot be firmly excluded in the absence of structural data. It seems more likely that the inhibition of the
S589C, -D, or -N substitution mutant by Cd2+ or Zn2+ is due to coordination with native cysteines in the internal pore of ENaC that become accessible to Cd2+ and Zn2+, due to the
Ser-589 mutation in the channel selectivity filter.
There are a large number of cysteines in the
-,
-, and
ENaC sequences that represent potential binding sites for Cd2+ ions in the internal pore of the channel. We have limited our analysis to conserved regions of the N terminus, the TM1 and TM2 transmembrane segments that involve 13 cysteine residues. We initially planned to substitute all the 13 cysteines, but we quickly realized that we were unable to generate a functional channel in the background of the
S589N mutation when more than 5 substituted cysteines were mutated in
-,
-, or
ENaC subunits.
We have performed a first screen with different ENaC mutants in which native cysteines were substituted individually or in pairs in the
S589N mutant background. We have identified
Cys-546 as a potential binding site for Cd2+. Recordings in Fig. 10, A–C, show the time course of Cd2+ inhibition of the S589C, -D, and -N mutants with the substitution of the native cysteine to serine at position Cys-546 in
ENaC. When compared with the tracing in Fig. 2, the INa inhibition by 0.1 mM Cd2+ was almost negligible for the
S589C/D,
,
C546S mutants and considerably reduced at 1 mM for the
S589N,
,
C546S. Fig. 10 (bottom in each panel) displays the effect of the
C546S mutation on the time course of INa inhibition by Cd2+ of the
S589C, -D, -N mutants. At all the Cd2+ concentrations tested, the
C546S substitution decreases the magnitude of the INa inhibition by Cd2+, but current inhibition persists at high Cd2+ concentrations. Such INa inhibition in the presence of Cd2+ is expected for a channel mutant with a permeability to Cd2+ ions that is lower than for Na+ ions since the slower diffusion of Cd2+ along the pore will consequently reduce as well that of Na+.
We asked whether the lower sensitivity of the
C546S mutant to block by Cd2+ might be related to a faster dissociation rate from its binding site and tested the recovery of the
S589C,
,
C546S,
S589D,
,
C546S, and
S589N,
,
C546S mutants from Cd2+ block at millimolar concentrations. INa recordings of the
S589C,
,
C546S,
S589D,
,
C546S, and
S589N,
,
C546S mutants in Fig. 11A show that, after the Cd2+-dependent decrease in INa, removal of external Cd2+ allowed a fast and almost complete recovery of INa. These experiments show that the
Cys-546 is responsible for the almost irreversible trapping of Cd2+ within the pore that leads to the channel block.
 |
DISCUSSION
|
|---|
The ENaC channel is insensitive to block by external Cd2+ but is highly sensitive to block by Cd2+ applied at micromolar concentrations from the intracellular side of the membrane (13). The cysteine substitution
S589C has two major consequences on channel function; first, it confers a block by externally applied Cd2+ or Zn2+ ions, and second, it changes the ion selectivity of the channel (11). Mutations at position
Ser-589 have been shown to drastically change the ion selectivity of ENaC, allowing divalent cations to pass through the channel. Detectable currents carried by divalent cations such as Sr2+ or Ca2+ could be measured through
S589C and
S589D ENaC mutants (9).
The aim of this work was to understand the molecular mechanism of the block of the
Ser-589 ENaC mutants by extracellular Cd2+ and to identify the amino acid residues coordinating Cd2+. We have hypothesized that external Cd2+ ions are unable to block wild-type ENaC essentially because the channel is impermeable to divalent cations. Rendering ENaC permeable to divalent cations by mutations at residues in the selectivity filter such as the
Ser-589 should make the channel sensitive to block by external Cd2+ in a way similar to the ENaC block by internally applied Cd2+. This approach could be applied to identify the residues lining the conductive pore and therefore to better understand the structure of ENaC.
It has been recently proposed that the block of the
S589C ENaC mutant by Cd2+ results from the coordination of Cd2+ ions with the sulfhydryl group of the
589 cysteine pointing toward the channel pore (11). The contribution of this cysteine site chain in coordinating Cd2+ ions seems questionable since alternative
Ser-589 substitutions such as
S589N render ENaC equally sensitive to block by Cd2+. Therefore, a sulfhydryl group at serine 589 is not necessary for Cd2+ block of the
S589C mutant, and it is difficult on this basis to draw any conclusion about the side chain orientation of the residue at
Ser-589 relative to the channel pore. The extremely weak inhibition of the
S589D mutant by external Ca2+ at concentrations as high as 10 mM further supports the absence of interaction between divalent cations in the channel pore and the side chain residue at position
Ser-589. It remains likely that, as for the KcsA K+ channel, the selectivity filter of ENaC is lined essentially by the backbone atoms of the G/SXS sequence as has been already proposed (10).
Our observations are consistent with a mechanism for Cd2+ blocking of the
S589C mutant that involves a change in the selectivity filter allowing the access for external Cd2+ ions to a binding site within the internal pore. The block of
S589C,
S589D, and
S589N by Cd2+ is characterized by a slow on-rate and an equally slow and partial recovery from blockade. These blocking kinetics are clearly different from those of
S583C ENaC block by Cd2+. This latter mutant with the substitution located in the amiloride binding site at the outer entrance of the channel pore shows a fast and fully reversible current inhibition by submillimolar Cd2+ or Zn2+ consistent with the accessibility of the cysteine sulfhydryl group at position
583 to permeant ions. The slow on-rate of
S589C block by Cd2+ rather suggests the presence of significant diffusional constraints for Cd2+ to reach a site within the channel pore where it binds nearly irreversibly and with high affinity. This is illustrated in our experiments by the fact that the concentration of external Cd2+ between 10 µM and 1 mM mainly affects the on-rate of block and has relatively little effect on the maximal current inhibition.
Our experimental data provide little evidence for a direct interaction between Cd2+ and the sulfhydryl group of the cysteine at position
589. The question remains where does Cd2+ bind? The voltage dependence of the channel block by Cd2+ indicates that this cation binds within the transmembrane electric field. In addition, we provide strong evidence that Cd2+ binds in the channel pore, since amiloride, the classical pore blocker, of ENaC prevents Cd2+ from blocking the channel. Thus, Cd2+ binds at a site located deeper in the channel pore with respect to the amiloride binding site and likely beyond the selectivity filter since the
Ser-589 mutations altering the channel ionic selectivity are required for Cd2+ block. The Ser-589 in the
ENaC is in close vicinity of the amiloride binding site corresponding to
S583C, and experimental evidence is consistent with
Ser-589 participating in the narrowest part of the channel pore at the selectivity filter.

View larger version (40K):
[in this window]
[in a new window]
|
FIGURE 11. The C546S mutation affects the recovery from Cd2+ block. A, recordings of INa in oocytes expressing S589C, , C546S, S589D, , C546S, or S589N, , C546S after Cd2+ exposure (1 or 10 mM) and after Cd2+ removal. B, summary of INa recovery after Cd2+ removal. ( S589C, , C546S, n = 12; S589D, , C546S, n = 8; or S589N, , C546S, n = 5).
|
|
Our experiments support the view that the substitutions at position Ser-589 in the
ENaC subunit result in steric modifications of the channel pore that allow externally applied Cd2+ to reach a binding site normally inaccessible within the internal pore of ENaC located beyond the selectivity filter. Wild-type ENaC is blocked by micromolar concentrations of Cd2+ applied from the intracellular side, and this block shares two important characteristics with the block of
S589C mutant by extracellular Cd2+: it displays both an affinity in the micromolar range and is slowly and only partially reversible. The steric modifications resulting from
Ser-589 mutations affect the ionic selectivity of ENaC, making the channel more permeable to K+ and Ca2+. It has not been possible to show that the
Ser-589 mutants are permeable to Cd2+ or Zn2+ ions, since both divalent cations block the channel, but it remains very likely that the steric modifications in the narrowest part of ENaC, due to
Ser-589 mutation, allow Cd2+ ions to pass the selectivity filter and to bind cysteine residues located along the channel pore. In the case of wild-type ENaC, these binding sites for Cd2+ are only accessible from the intracellular side.
The
Ser-589 ENaC mutants provide an interesting model to identify the cysteine residues that coordinate Cd2+ ions along the ion permeation pathway. Unfortunately, in our search for cysteines interacting with Cd2+, we were limited by the low amiloride-sensitive current of the cysteine substitution ENaC mutants performed in the background of the
Ser-589 mutations. It was thus difficult to obtain a complete picture of the cysteines lining the internal pore of the channel. However, we identified Cys-546 in the TM2 of the
ENaC subunit as a residue that contributes to the channel block by Cd2+. First, the
C546S mutation decreases the apparent affinity for Cd2+ of a site that is responsible for the fast component of the channel inhibition. Second, the
C546S substitution makes the channel block by Cd2+ rapidly reversible. Such increase in the off-rate of Cd2+ blocking kinetics represents a strong argument supporting both a direct participation of the
Cys-546 in the coordination of Cd2+ ion and the orientation of the sulfhydryl group of
Cys-546 toward the ion permeation pathway. The
Cys-546 residue is likely the first accessible site for external Cd2+ ions, and Cd2+ binding to this site results in a channel block. The slower component of the Cd2+ block seems unaffected by
Cys-546 mutation, suggesting the presence of a deeper and less accessible site for binding Cd2+ along the internal part of the channel pore. The
Cys-546 may not be the only residue involved in the coordination with Cd2+ ions. The identification of additional cysteine partners involved in binding interactions with Cd2+ ion requires the substitution of these cysteines in the background of the
Ser-589 and
Cys-546 mutations. Unfortunately, these ENaC constructs did not express measurable amiloride-sensitive currents.
Even though several structural models have been proposed, the structure of the ion channel pore of the members of the ENaC/degenerin family has yet not been elucidated (16, 18). Functional analysis of voltage-dependent blocking of ENaC by impermeant cations supports a funnel-like structure of the external conduction pore of ENaC that can accommodate amiloride in its outer mouth (position 583 in the rat ENaC sequence) and then narrowing down to the selectivity filter (G/SXS sequence, Fig. 1) (19). The primary sequence of this pore region (Ser-583-Ser-589 in rat
ENaC, Fig. 1) does not allow reliable secondary structure predictions. However, the second transmembrane domain starting at the conserved Val residue Val-590 conforms to a highly probable
helix (Fig. 1) (8). The side chain orientation of the amino acid residues lining the pore region has clearly been demonstrated for the residues involved in the binding interactions with amiloride, i.e. Ser-583 in the
ENaC (Fig. 1) and the corresponding glycine residues in the
and
ENaC subunits (17). The thiol side chains of cysteine substitutions at positions Leu-584, Trp-585, Phe-586, and Ser-588 in the
ENaC sequence are not accessible to sulfhydryl reagents such as methanethiosulfonates or Cd2+ (16). Similar data were obtained with cysteine substitutions on
ENaC. From our data little evidence supports the interaction between Cd2+ or Ca2+ with the side chain of aspartate or cysteine, respectively, at position
589. We have not analyzed in detail the mechanism of block by Cd2+ of the
G587C mutant, but the characteristics of this block are basically similar to that of the
S589C mutant (11). Thus, from this experimental evidence, the
Ser-583 appears to be the only residue in the pore region sequence having its side chain facing the ion conduction pore and interacting with ions present in the pore lumen. Amino acid substitutions of the corresponding glycine in
(Gly-525) and
(Gly-537) ENaC subunits suggest orientations of these residues similar to Ser-583 in
subunit (17, 20).
The second transmembrane
helix likely starts with residue Val-590, according to model predictions of the
ENaC subunit (Fig. 1) (8). The Cys-546 in the
ENaC interacts with permeant Cd2+ ions in the background of the
Ser-589 mutation, providing strong evidence that the thiol side chain is facing the ion conduction pore. It is therefore likely that
Cys-546 is accessible to permeant ions after passing successively through the external pore and the selectivity filter. This represents the first evidence for the contribution of the second transmembrane segment to the internal pore lining. A previous cysteine accessibility scan performed on ASIC1a using methanethiosulfonates applied from the intracellular side of the channel revealed that cysteines introduced at several positions corresponding in the
ENaC sequence to Val-547, Ile-548, and Ile-550, as well as others located more distally in the TM2, were inaccessible to MTSET, i.e. did not interact with internal MTSET to block the channel (14). Thus, according to the presently available experimental evidence, it seems that only the first residues in the proximal part of the TM2 corresponding to position
Cys-546 participate in the pore lining. In the KcsA, the distal part of TM2 forms the tip of "inverted tepee" architecture that corresponds to the intracellular end of the conduction pore (12). Recent evidence suggests that the intracellular start of the TM1 and part of the amino terminus of ASIC and ENaC channels participate to the inner pore structure (13, 14). We can therefore conclude that the ion conduction pore of ENaC/ASIC channels does not conform to the general structural feature of the potassium channels.
 |
FOOTNOTES
|
|---|
* This work was supported in part by Swiss National Science Foundation Grant 3100A0-108069. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 
1 Recipient of a fellowship from the Novartis Foundation (05B41). 
2 To whom correspondence should be addressed: Dept. of Pharmacology and Toxicology, Faculty of Biology and Medicine, University of Lausanne, Bugnon 27, 1005 Lausanne, Switzerland. Tel.: 41-21-692-53-80; Fax: 41-21-692-53-55; E-mail: Laurent.Schild{at}unil.ch.
3 The abbreviations used are: ENaC, epithelial Na+ channel; ASIC, acid-sensing ion channel; MTS, methanethiosulfonate; TM1/TM2, transmembrane segment 1/2. 
 |
ACKNOWLEDGMENTS
|
|---|
We thank Jean-Daniel Horisberger and Stephan Kellenberger for critical reading of the manuscript.
 |
REFERENCES
|
|---|
- Kellenberger, S., and Schild, L. (2002) Physiol. Rev. 82, 735–767[Abstract/Free Full Text]
- Loffing, J., Zecevic, M., Feraille, E., Kaissling, B., Asher, C., Rossier, B. C., Firestone, G. L., Pearce, D., and Verrey, F. (2001) Am. J. Physiol. 280, F675–F682
- Lifton, R. P., Gharavi, A. G., and Geller, D. S. (2001) Cell 104, 545–556[CrossRef][Medline]
[Order article via Infotrieve]
- Boucher, R. C. (2004) Eur. Respir. J. 23, 146–158[Abstract/Free Full Text]
- Firsov, D., Gautschi, I., Merillat, A. M., Rossier, B. C., and Schild, L. (1998) EMBO J. 17, 344–352[CrossRef][Medline]
[Order article via Infotrieve]
- Kosari, F., Sheng, S. H., Li, J. Q., Mak, D. D., Foskett, J. K., and Kleyman, T. R. (1998) J. Biol. Chem. 273, 13469–13474[Abstract/Free Full Text]
- Kellenberger, S., Gautschi, I., and Schild, L. (2003) Mol. Pharmacol. 64, 848–856[Abstract/Free Full Text]
- Rost, B., Yachdav, G., and Liu, J. (2004) Nucleic Acids Res. 32, W321–W326[Abstract/Free Full Text]
- Kellenberger, S., Gautschi, I., and Schild, L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4170–4175[Abstract/Free Full Text]
- Kellenberger, S., Auberson, M., Gautschi, I., Schneeberger, E., and Schild, L. (2001) J. Gen. Physiol. 118, 679–692[Abstract/Free Full Text]
- Sheng, S., Perry, C. J., Kashlan, O. B., and Kleyman, T. R. (2005) J. Biol. Chem. 280, 8513–8522[Abstract/Free Full Text]
- Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A. L., Gulbis, J. M., Cohen, S. L., Chait, B. T., and MacKinnon, R. (1998) Science 280, 69–77[Abstract/Free Full Text]
- Kellenberger, S., Gautschi, I., Pfister, Y., and Schild, L. (2005) J. Biol. Chem. 280, 7739–7747[Abstract/Free Full Text]
- Pfister, Y., Gautschi, I., Takeda, A. N., van Bemmelen, M., Kellenberger, S., and Schild, L. (2006) J. Biol. Chem. 281, 11787–11791[Abstract/Free Full Text]
- Ravindran, A., Schild, L., and Moczydlowski, E. (1991) J. Gen. Physiol. 97, 89–115[Abstract/Free Full Text]
- Sheng, S. H., Li, J. Q., Mcnulty, K. A., Kieber-Emmons, T., and Kleyman, T. R. (2001) J. Biol. Chem. 276, 1326–1334[Abstract/Free Full Text]
- Schild, L., Schneeberger, E., Gautschi, I., and Firsov, D. (1997) J. Gen. Physiol. 109, 15–26[Abstract/Free Full Text]
- Li, J., Sheng, S., Perry, C. J., and Kleyman, T. R. (2003) J. Biol. Chem. 278, 13867–13874[Abstract/Free Full Text]
- Palmer, L. G. (1990) Renal Physiol. Biochem. 13, 51–58[Medline]
[Order article via Infotrieve]
- Snyder, P. M., Olson, D. R., and Bucher, D. B. (1999) J. Biol. Chem. 274, 28484–28490[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| This Article |
 |
 |
Abstract
|
 |
Full Text (PDF)
|
 |
All Versions of this Article:
282/44/31928
most recent
| |